Written by Klarity Editorial Team
Published: Jul 16, 2026

Last updated: July 16, 2026
Key 2026 Update: UnitedHealthcare (UHC) members in Hawaii may access ADHD medications through OptumRx, UHC’s pharmacy benefit manager. Most brand-name ADHD stimulants typically require prior authorization (PA) and step therapy in 2026. Generic stimulants are generally available at Tier 1–2. See if Klarity’s ADHD treatment may work with your UHC plan.
UnitedHealthcare is one of the most widely available commercial health insurers in Hawaii, offering plan types including HMO, PPO, and high-deductible health plans (HDHPs) across employer-sponsored and individual markets. Hawaii’s Prepaid Health Care Act (Haw. Rev. Stat. § 393) generally requires most employers to provide health coverage to qualifying employees, making UHC among the most commonly encountered insurers for Hawaii residents with workplace coverage.
For ADHD treatment — which may include psychiatric evaluation, therapy, and prescription stimulant or non-stimulant medication — UHC coverage in Hawaii is governed by the plan’s evidence of coverage (EOC), OptumRx formulary, and Hawaii’s mental health parity law (Haw. Rev. Stat. § 431M-1 et seq.).
Important: Coverage details vary significantly by specific plan. Always verify your benefits directly with UHC before scheduling an appointment or filling a prescription.
UHC uses OptumRx as its pharmacy benefit manager. Below is a general representation of how common ADHD medications may be tiered on OptumRx commercial formularies in 2026. Exact tier placement and PA requirements vary by your specific UHC plan in Hawaii.
| Medication | Type | Schedule | Typical Tier | PA Often Required? |
|---|---|---|---|---|
| Amphetamine salts (generic Adderall) | Stimulant | Schedule II | Tier 1–2 | Sometimes (plan-specific) |
| Methylphenidate (generic Ritalin/Concerta) | Stimulant | Schedule II | Tier 1–2 | Sometimes |
| Lisdexamfetamine generic | Stimulant | Schedule II | Tier 2–3 | Yes — verify with plan |
| Adderall XR (brand) | Stimulant | Schedule II | Tier 3–4 | Yes — step therapy |
| Vyvanse/brand lisdexamfetamine | Stimulant | Schedule II | Tier 3–4 | Yes — step therapy |
| Concerta (brand methylphenidate ER) | Stimulant | Schedule II | Tier 3–4 | Yes — step therapy |
| Atomoxetine (generic Strattera) | Non-stimulant | Non-scheduled | Tier 2–3 | Sometimes |
| Guanfacine ER (generic Intuniv) | Non-stimulant | Non-scheduled | Tier 1–2 | Rarely |
| Clonidine ER (generic Kapvay) | Non-stimulant | Non-scheduled | Tier 1–2 | Rarely |
| Viloxazine (Qelbree) | Non-stimulant | Non-scheduled | Tier 2–3 | Sometimes |
| Strattera (brand atomoxetine) | Non-stimulant | Non-scheduled | Tier 3–4 | Yes — step therapy |
Note: Tier placement and PA requirements vary by plan year and specific UHC plan type. Generic lisdexamfetamine (generic Vyvanse) has become available — verify coverage and tier placement with your specific plan before filling.
Hawaii requires Electronic Prescribing for Controlled Substances (EPCS) for Schedule II controlled substances under Haw. Rev. Stat. § 329-38.5. This is an important distinction from some other states:
Unlike West Virginia and some other states that mandate EPCS for all controlled substance schedules, Hawaii’s requirement is limited to Schedule II. Benzodiazepines (Schedule IV) and other non-Schedule II controlled substances are not subject to Hawaii EPCS requirements. For ADHD specifically, this means that stimulant prescriptions require EPCS while non-stimulant prescriptions do not.
Klarity Health’s licensed providers use EPCS-compliant prescribing systems and can prescribe Schedule II stimulants electronically within Hawaii’s legal framework.
Prior authorization (PA) is a common requirement for brand-name ADHD medications under UHC/OptumRx in 2026. The PA process typically involves your provider documenting:
PA requests for UHC members are generally submitted through UHC’s provider portal (uhcprovider.com) or by phone. Standard PA decisions are typically issued within 2–3 business days; urgent requests are generally processed within 24–72 hours.
If your PA is denied, you have the right to request a first-level internal appeal, followed by an external independent review if needed. Hawaii’s parity law requires that PA standards for mental health conditions — including ADHD — be no more restrictive than those applied to comparable medical and surgical conditions.
Hawaii’s Mental Health Parity Law (Haw. Rev. Stat. § 431M-1 et seq.) requires health insurers to provide benefits for mental health and substance use disorders that are no less favorable than those provided for comparable medical and surgical conditions. For ADHD patients, parity protections may apply to:
Under parity, if UHC does not impose step therapy for a chronic physical condition medication, it generally may not impose more restrictive step therapy requirements for ADHD medication management. If you believe your UHC plan is applying PA or step therapy requirements more strictly for ADHD than for comparable physical conditions, you may file a complaint with the Hawaii Insurance Division at 1-808-586-2790.
Note: If your coverage is through a large self-funded employer plan, federal ERISA may preempt state parity law. The federal Mental Health Parity and Addiction Equity Act (MHPAEA) still applies in most cases. Verify with your employer’s HR department whether your plan is state-regulated or self-funded.
Hawaii’s Prepaid Health Care Act (Haw. Rev. Stat. § 393) generally requires most Hawaii employers to provide health care coverage for employees who work at least 20 hours per week. This means a large proportion of working adults in Hawaii have employer-sponsored coverage, often through insurers like UHC.
If you receive UHC coverage through your employer in Hawaii:
UHC health plans in Hawaii may cover a range of ADHD treatment services, subject to your specific plan’s benefits and any applicable deductibles or copays:
Klarity Health connects patients in Hawaii with 2,000+ licensed psychiatric providers — including psychiatrists and psychiatric nurse practitioners — who specialize in ADHD evaluation and treatment. Klarity providers use EPCS-compliant prescribing systems for Schedule II stimulants, meeting Hawaii’s requirements under HRS § 329-38.5.
Check if Klarity’s ADHD treatment may work with your UHC plan in Hawaii.
Many UHC plans in Hawaii may cover an initial psychiatric evaluation for ADHD diagnosis under mental health benefits. The evaluation may be subject to your plan’s deductible, copay, or coinsurance. Telehealth evaluations are often covered as well. Verify your specific benefits with UHC at 1-866-892-5890 before booking.
Generic amphetamine salts (the generic form of Adderall) are typically covered at Tier 1–2 on OptumRx commercial formularies and may be available with a relatively low copay. Brand-name Adderall XR typically requires step therapy and prior authorization and is placed at a higher tier. Check your specific plan’s formulary at myuhc.com or by calling OptumRx at 1-800-788-4863.
Brand lisdexamfetamine (Vyvanse) is typically placed at Tier 3–4 and usually requires PA and step therapy demonstrating a trial with a lower-tier stimulant. A generic form of lisdexamfetamine has become available and may be covered at a lower tier — verify with your specific UHC plan before requesting a prescription.
No. Hawaii requires electronic prescribing (EPCS) for Schedule II controlled substances under Haw. Rev. Stat. § 329-38.5, which includes all stimulant ADHD medications. Paper prescriptions for Schedule II stimulants are generally not accepted unless a specific exemption applies. Non-stimulant ADHD medications (atomoxetine, guanfacine ER, etc.) are not Schedule II and are not subject to Hawaii’s EPCS requirement.
You have the right to appeal a PA denial. Your provider can submit a first-level internal appeal with additional clinical documentation. If the internal appeal is denied, you may request an external independent review. Hawaii’s parity law (Haw. Rev. Stat. § 431M-1 et seq.) requires that PA criteria for ADHD be no more restrictive than for comparable medical conditions — this is often a key argument in successful appeals. Contact the Hawaii Insurance Division at 1-808-586-2790 if you believe your plan is applying parity inconsistently.
Hawaii’s Prepaid Health Care Act (HRS § 393) generally requires most employers to provide health insurance to qualifying employees, but it does not specify minimum ADHD benefit standards. The specific ADHD services and medications covered by your UHC plan depend on the plan your employer chose. Verify your benefits with UHC or review your Summary Plan Description (SPD) from your employer’s HR department.
Disclaimer: This article is for informational purposes only and does not constitute medical or legal advice. Insurance coverage varies by individual plan, employer, and market type. Coverage descriptions reflect general OptumRx formulary patterns and may not apply to your specific plan. Always verify your exact benefits with UHC before scheduling treatment or filling a prescription. Klarity Health does not guarantee coverage for any specific service.
Find the right provider for your needs — select your state to find expert care near you.